Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Are you still in this? Going to be a fantastic year. Japan just approved Orladeyo, UK next. Continuing to rise. Last conference was very exciting with Factor D moving forward. No doubt over a hundred in 2023. Over 10 today!
Only to prevent lawsuits. Once ststute of limitations expires the company dissolves. All the while another pick has tripled. Seeya!
Exactly, 8k is filed. 10K will have updates, 10Q will have revenues, 2nd 10Q will include Japans revenues, 3rd 10Q will have UK revenues, and all for Orladeyo. The factor D and galidesivir going to make this a hundred dollar stock by 2022/23. Exciting times ahead.
better yet, he dissolves the company, takes a tax loss which will offset his gains of his other company. depending on canada tax laws of course, but easily done. Will probably happen shortly after he sells the property and claims that money for partial payment on his 12 percent interest note.
The big pharma companies steer away from rare diseases. not enough money in it. That's where these smaller companies come in. Wouldn't be til 2023 when factor D is fully vetted that a large company would be interested. By then we could be at 200 per share or above,
you don't. ceo himself said they do what the big guys can't. This stock will be over 100 due to factor D , Orladeyo, and even galidesivir. getting bought out may give shareholders a premium on todays prices but nowhere near what we will soon see on its own.
yes indeed. once I hit a million in bcrx it will be hard not to sell. with a military retirement, 401k, Ira, social security, will be no need to get more. 120 by 2023 at the very latest.
With Japans approval 10 to 11 pps. Uk Approval 15. Factor D - over 100!
Bought another 540 shares at 9.00 now have almost 9000 shares. When at 120 per share it will be time to fully retire.
Because people refuse to believe they've been scammed. Refuse to listen to common sense while being brainwashed by bs documentation. I mean really, zero business activity since 2013, never in the companies history of a single sale. Heddle stated for years that business has been suspended and now he states they no longer manufacture processors. He now must wait the full 3 years from the nulixo statement so the statute of limitations runs out. Then bankruptcy or dissolvement will take place.
Sales of what?
The best way for municipalities is to get rid of their waste as cheaply as possible. That is definitely not P2O. Burying is the cheapest and always will be.
But a great indicator of the future. Scams do not suddenly become legitimate.
Step down? To whom? He's the one sole employee.
Lets be perfectly straight here. The agreement is only effective upon the sale of the first processor. So if no processor has been sold then there is no agreement. Since P2O no longer makes processors there will never be a sale and therefore there will never be an agreement. It is null and void. Since Heddle is not trying to find other clients is it not obvious that this company is truly dead?
So all they (steve price) have is ideas? So their Apr 2020 update was all lies?
Seeing as P2O no longer makes processors would that not nullify this agreement?
Buy what? P2O does not sell processors! See financials signed by Heddle.
1st sale of what? P2O no longer manufactures processors.
Every quarter. May have an update with 10K, but not financial numbers as insurance payments probably won't hit the books until Jan. 1st major update expected with 1st qtr report. Expect Japan approval next week with spike to $10.00 per. UK approval by end of March, though the UK has approved Orladeyo for use prior to official approval. See my previous post for link.
More interesting though will be their updates on their Factor D. My sell point is $120.00. Expected in 2023.
metformin is dangerous, 1st hand experience!
Hopefully a higher close as investors buy in before the long weekend. With Japans approval any day now and U.S. markets closed on Monday investors just might want to get ahead of the expected spike over 9/10 dollar range. If approval comes Monday shorts will be screwed. Last hour of trading will be very interesting.
Heddle has discontinued all operations...past present and future. Nulixo is a scam just like econav and veridisyn. All it takes is 2 phone calls. One to Heddle and another to Nulixo. Stock documentation on a dead company is pointless.
Fantastic news! 20 dollar end of year prediction may be too conservative.
Small company like this is much better suited in the critical area of rare diseases. Key word rare. I believe that was discussed at the jpm conference. Biocryst will soar on its own. Will be much better for shareholders if they remain as is and make us all millionaires.
And the nulixo bs continues. They refuse to fix their email or their website:
Sorry, we were unable to deliver your message to the following address.
<info@nulixo.com>:
550: 5.1.1 The email account that you tried to reach does not exist. Please try
5.1.1 double-checking the recipient's email address for typos or
5.1.1 unnecessary spaces. Learn more at
5.1.1 https://support.google.com/mail/?p=NoSuchUser a13si1054967qtn.367 - gsmtp
Incorrect!
Not a covid trial though! Immune boost trial maybe, but ingredients and their effect is already known.
Conference notes will be digested by many tonight. Expect a boost with Japan and UK approvals. Ultimate rise into the 20's will begin when 1st qtr revenues are reported.
sold into the bid. Maybe a long needed a gallon of milk.
Covid trial? Thats funny!
Exactly. And just who is getting the "consultation" shares. Those are not restricted. Ordinary shareholders are being diluted into oblivion.
You need to look annually! Read the financial reports. Then ask, exactly who is getting all these shares.
Another volume day! Documentation should be very interesting!
Tens of Millions more diluted shares added to OS.
A very good conference. 2021 is going to be my best year ever! BCRX leading the way.
10K should be telling soon. Especially section on current events since end of teport date. That will then lead into the 1st qtr 10Q.
So far I was right mid day above 8. Hope it stays above 8 prior to tomorrows conference.
With the conference presentation tomorrow at 11:40 AM that may be the only "pr".
Wednesday will be quite exciting.